Literature DB >> 21671894

Guidelines on oral anticoagulation with warfarin - fourth edition.

David Keeling1, Trevor Baglin, Campbell Tait, Henry Watson, David Perry, Caroline Baglin, Steve Kitchen, Michael Makris.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21671894     DOI： 10.1111/j.1365-2141.2011.08753.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN： 0007-1048            Impact factor:   6.998


× No keyword cloud information.
  127 in total

Review 1.  Cerebrospinal fluid and lumbar puncture: a practical review.

Authors:  Ben L C Wright; James T F Lai; Alexandra J Sinclair
Journal:  J Neurol       Date:  2012-01-26       Impact factor: 4.849

Review 2.  Antidotes to coumarins, isoniazid, methotrexate and thyroxine, toxins that work via metabolic processes.

Authors:  D Nicholas Bateman; Colin B Page
Journal:  Br J Clin Pharmacol       Date:  2015-10-24       Impact factor: 4.335

3.  Factors driving anticoagulant selection in patients with atrial fibrillation in the United States.

Authors:  Julie C Lauffenburger; Joel F Farley; Anil K Gehi; Denise H Rhoney; M Alan Brookhart; Gang Fang
Journal:  Am J Cardiol       Date:  2015-02-02       Impact factor: 2.778

Review 4.  Clinical use and the Italian demand for prothrombin complex concentrates.

Authors:  Massimo Franchini; Giancarlo M Liumbruno; Monica Lanzoni; Fabio Candura; Stefania Vaglio; Samantha Profili; Giuseppina Facco; Gabriele Calizzani; Giuliano Grazzini
Journal:  Blood Transfus       Date:  2013-09       Impact factor: 3.443

5.  Tips for GP trainees working in haematology.

Authors:  Simon Glew; Gillian Horne; Paul Ryan
Journal:  Br J Gen Pract       Date:  2013-06       Impact factor: 5.386

Review 6.  Pharmacogenetics of warfarin: challenges and opportunities.

Authors:  Ming Ta Michael Lee; Teri E Klein
Journal:  J Hum Genet       Date:  2013-05-09       Impact factor: 3.172

7.  Warfarin untargeted metabolomics study identifies novel procoagulant ethanolamide plasma lipids.

Authors:  Hiroshi Deguchi; Darlene J Elias; Sunia Trauger; Hui-Min Zhang; Ewa Kalisiak; Gary Siuzdak; John H Griffin
Journal:  Br J Haematol       Date:  2014-01-23       Impact factor: 6.998

Review 8.  Non-Vitamin K Oral Anticoagulants (NOACs) and Their Reversal.

Authors:  Sujan T Reddy; T C Cossey; Sean I Savitz; James C Grotta
Journal:  Curr Neurol Neurosci Rep       Date:  2017-09       Impact factor: 5.081

9.  Analysis of the first therapeutic-target-achieving time of warfarin therapy and associated factors in patients with pulmonary embolism.

Authors:  Xiaowei Gong; Haiyan Wang; Yadong Yuan
Journal:  Exp Ther Med       Date:  2016-08-23       Impact factor: 2.447

Review 10.  Duration of anticoagulation treatment for thrombosis in APS: is it ever safe to stop?

Authors:  Sinthiya Punnialingam; Munther A Khamashta
Journal:  Curr Rheumatol Rep       Date:  2013-04       Impact factor: 4.592
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.